U

University Eye Specialists | Clinical Research Department

Research site
(Unclaimed)
Location
622 Smithview Drive, Maryville, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Timolol Maleate
Latanoprost
Netarsudil
AR-15512
H-1337
STN1013600
Bimatoprost
AR-17043
DE-126
PG043

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes (EVOLVE)

A Randomized Clinical Trial of Ab Interno Canaloplasty and Trabeculotomy with the OMNI® Surgical System Compared to Standard Medical Treatment in Pse...

Begins enrollment this month
Primary Open Angle Glaucoma
Device: OMNI Surgical System
Drug: Latanoprost plus adjunctive glaucoma medication

The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects...

Begins enrollment in 2 months
Open Angle Glaucoma
Ocular Hypertension
Drug: AR-17043 Ophthalmic Solution
Drug: Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution

A study of the Streamline Surgical System versus competitor

Enrolling
Open Angle Glaucoma
Device: iStent Inject W
Device: Streamline Surgical System

The trial will evaluate the safety and efficacy of 3 dose regimens of H-1337 \[0.6% twice daily (b.i.d.), 1.0% b.i.d. and 1.0% once in the morning (q...

Enrolling
Glaucoma Open-Angle Primary
Ocular Hypertension
Drug: H-1337 Placebo
Drug: H-1337 1.0%

Trial sponsors

S
S
Aerie Pharmaceuticals logo
Alcon logo
D
F
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems